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Abstract The objective of this study is to provide a
critical overview of available instruments to assess
impairments in patients with rheumatic disorders, and to
recommend reliable and valid instruments for use in
allied health care and rehabilitation medicine. A com-
puter-aided literature search (1982–2004) in several da-
tabases was performed to identify studies focusing on
the clinimetric properties of instruments designed to
assess impairments in function in patients with rheu-
matic disorders. Data on intra-rater reliability, inter-
rater reliability and construct validity were extracted in a
standardized way. Explicit criteria were applied for
reliability and validity. Results: The search identified a
total of 49 instruments to assess impairments in func-
tions in patients with rheumatic disorders; 19 met the
criteria for reliability, 22 met the criteria for validity, and
11 out of the 49 appeared to meet the criteria for both
reliability and validity. In summary, evidence of both
reliability and validity was only found for 11 out of 49
instruments for the assessment of impairments in pa-
tients with rheumatic disorders. Only a limited number
of the identified instruments for the assessment of
impairments is both reliable and valid. Allied health care
professionals should be cautious in the selection of
measurement instruments to assess their patients.
Keywords Outcome assessment Æ Measurement
instruments Æ Impairments Æ Rheumatic disorders Æ
Assessment Æ Construct validity Æ Reliability
Introduction
In rehabilitation medicine and allied health care for
patients with rheumatic disorders, attention has shifted
from disease severity to impairments, disabilities and
problems in participation [1]. In particular, the devel-
opment of the International Classification of Impair-
ments, Disabilities and Handicaps (ICIDH) [2] —after
its revision in the past decade now renamed the Inter-
national Classification of Functioning, Disabilities and
Health Problems (ICF) [3]—has encouraged this shift.
The ICF distinguishes the disease itself from disease
consequences and influencing contextual factors. In
rehabilitation medicine and allied health care, the
treatment goals cannot directly be derived from the
severity of the disease. If the treatment goals are ex-
pressed in terms of impairment, disability or problems in
participation (as in the ICF), these must be assessed and
objectified [4, 5].
From this point of view it is essential to choose
adequate measurement instruments, based on the evi-
dence of their methodological quality [4, 6–11].
This study focuses on the psychometric properties of
instruments to measure impairments in functions in the
body and structures of patients with rheumatic disor-
ders, a population which is frequently treated with
physiotherapy and occupational therapy. ‘‘Impairment‘’
is defined as any significant loss or abnormality of psy-
chological, physiological or anatomical structure or
function. Impairment is part of a health condition, but
does not necessarily indicate that a disease is present or
that the individual should be regarded as sick [12].
‘‘Disabilities’’ are defined as limitations in the perfor-
mance of a task or action by an individual [12]. We
recently demonstrated that 57% of all available instru-
ments to assess people with rheumatic disorders focus on
impairments [13]. We started to focus on instruments to
measure impairments because of this dominance. In the
majority of clinical situations (60%), instruments are
used to measure status praesens of the patient [13].
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Inter-rater and intra-rater reliability are the first
characteristic of an instrument that are required to be
adequate; if a measurement is not reproducible it will
not be useful. Furthermore, an important requirement
of a measurement scale is the unidimensionality of
subscales. If sufficient reliability has been demonstrated,
it is also relevant to assess the validity.
In the literature, several aspects of validity are de-
scribed, but construct validity is the most commonly
assessed aspect. An instrument can be validated by
studying its correlation with an optimally-comparable
construct (e.g., the same impairment) or by correlation
with an imperfect construct, such as gender, age, etc. In
this study we distinguished various levels of construct
validity, because we expected to find higher correlation
values if measurement instruments were validated
against an optimally-comparable construct than if vali-
dated against an imperfect construct [14]. If so, this
could be relevant for interpretation of validity studies.
The aim of this study was threefold. The first objec-
tive was to make an inventory of available instruments
and questionnaires for the assessment of impairments in
patients with rheumatic disorders. The second aim was
to investigate which of these instruments have accept-
able methodological quality with regard to reliability
and validity. The third aim was to investigate the
assumption that construct validity results in higher
correlation values when validated against a more suit-
able construct.
Method and materials
We performed a systematic review of the literature on
the methodological characteristics of measurement
instruments for all impairments that are relevant in al-
lied health care for patients with rheumatic disorders.
The term ‘‘measurement instrument’’ includes ques-
tionnaires (to be completed by the patient), observation
lists (to be completed by the researcher) and anthropo-
metric measurement instruments (technical measure-
ment tools). Not all reported properties of instruments
are appropriate for all kind of instruments. For exam-
ple, inter-rater reliability (the degree to which two or
more observers can obtain the same ratings) is inap-
propriate for questionnaires that are completed by the
patient.
Inclusion procedure
The following criteria were applied:
– All studies had to focus on patients suffering from
rheumatoid arthritis, seronegative polyarthritis
(including psoriatic arthritis), osteoarthritis, ankylos-
ing spondylitis, polymyositis or fibromyalgia.
– The studies had to contain information about the
psychometric properties of instruments to assess
impairments in mental functions, stiffness, pain, joint
mobility (in terms of Range of Motion), muscle force
and swelling (ICIDH-classification) [15].
– Many questionnaires focus on more than one domain
of the ICIDH-classification, or measure more than
one variable. Included were: (1) instruments which
focus mainly (50% or more of the items) on the
impairment to be measured; and (2) questionnaires
with a sub-scale for the impairment in question that
can be interpreted separately as a single entity.
– Different versions of an instrument were considered as
separate measurement instruments.
– Only instruments for the measurement of adult pa-
tients were included.
Because of the method of data-reduction as described
above, some frequently-used questionnaires, like the
Health Assessment Questionnaire (HAQ), or the Wes-
tern Ontario McMaster Osteoarthritis Index (WO-
MAC), the EuroQoL and Nottingham Health Profile
are not included. The condition to be included was that
50% or more of the items should focus on the impair-
ment to be measured. Questionnaires like HAQ, WO-
MAC and Nottingham Health Profile predominantly
focus on disabilities.
Literature search
First the Medline database was searched for the period
January 1982–May 2004, using search terms for the
relevant rheumatic disorders and various search terms
for psychometric properties1. The database of the Centre
for Documentation of the Dutch Institute of Allied
Health Care was also searched for the period January
1988–May 2004, using the same keywords. Furthermore,
the search in both databases was repeated with the
names of the identified measurement instruments. Eng-
lish, French, German and Dutch literature was included.
The search was subsequently augmented with a manual
search based on the references of the relevant publica-
tions, and therefore the search also yielded some publi-
cations from before 1982. In total, 156 measurement
instruments were identified.
Data-extraction
All identified publications were assessed independently
on the basis of their title, and abstract by two reviewers
(RS and YK). In case of disagreement (3%) the article
was also assessed by a third reviewer. The assessment
was based on a standardized data-collection form
(R.A.B. Oostendorp et al., unpublished data). This form
consists of four sections: general description (name, first
1The detailed search strategy is available on request from the first
author
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author, etc.), assessment domain (according to the
ICIDH-classification), methodological aspects (con-
cerning reliability, validity) and aspects of utilization.
Methodological criteria for psychometric properties
We investigated the following psychometric properties:
intra-rater reliability, inter-rater reliability, construct
validity and responsiveness. To interpret the data on reli-
ability and validitywe used criteria based onDe Jong et al.
[17], Eliasziw et al. [18] and Doeglas et al. [19] (Table 1).
The cut-off points for ‘‘good’’ reliability are sup-
ported by Weiner and Stewart, who also suggested 0.85
as a criterion [20, 21].
To investigate the influence of validating against
different constructs (varying from optimally comparable
to imperfectly comparable) the construct validity was
divided into five clusters, in which the constructs against
which a measurement instrument is validated are defined
according to their anticipated degree of similarity to the
instrument at issue (Table 2).
‘‘Construct 1’’ is the most convergent construct, which
means that the validity is measured against a variable
which is very similar to the variable to be validated (e.g., a
pain-intensity questionnaire [variable pain] that is vali-
dated against a Visual Analogue Scale for pain). Validity
is defined as ‘‘construct 2’’ if the instrument is validated
against instruments that measure the same construct as
well as other impairments. ‘‘Construct 3’’ indicates that
the construct relates to other impairments than the
impairment to be validated. ‘‘Construct 4’’ relates to dis-
abilities, and not to impairments. ‘‘Construct 5’’ is the
least convergent validity, which means that the construct
that is used to validate a variable relates to other domains
than the variable that is to be validated (e.g., a pain-
intensity questionnaire (variable pain) that is validated
against disabilities in inter-personal relationships).
We clustered ‘‘construct 1’’ and ‘‘construct 2’’ as
‘‘optimally-convergent validity’’ and ‘‘construct 3’’,
‘‘construct 4’’ and ‘‘construct 5’’ as ‘‘imperfectly-con-
vergent validity’’. This distinction is also reflected in the
criteria for validity in the two last columns of Table 1.
The argument for this distinction is the fact that opti-
mally-convergent construct validity comes closest to the
gold standard, and is therefore expected to result in
higher values than imperfectly-convergent validity [14].
An explanation of all the abbreviations used in the
‘‘Result’’ section is given in the Appendix.
Data analysis
The data were analysed in the Statistical Package for
Social Sciences (SPSS) 8.0. A classification of instruments
was first made according to the type of impairments,
based on the domain of assessment (impairments) [12].
The values of different studies of the same instrument
were pooled for each psychometric property that was
assessed (reliability and construct validity, related to
sample size and correlation coefficients). By means of
statistical pooling taking sample sizes into account, the
results of separate studies on reliability and constructed
validity, expressed in correlation coefficients, were
combined into a single index. When the relevant infor-
mation was available, mathematical pooling of the data
was performed if the measurement instrument was val-
idated against the same construct. The values were






where X = pooled index, ni = number of persons in-
cluded in the study, xi = value of methodological aspect
(Pearson’s r, Spearman’s q or intra-class correlation
coefficient (ICC)) in the study, N = total number of
persons in all studies included in the pooling [22]. The
pooled index was computed for Pearson’s/Spearman’s
correlation coefficients and the ICC values separately.
Values for the construct validity of multidimensional
instruments can be strongly influenced by values of one
Table 1 Applied cut-off points
for intra-rater reliability, inter-
rater reliability and construct
validity
x = Pearson’s r, Spearman’s q










Good x ‡0.85 x ‡0.80 x ‡0.65 x ‡0.50
Moderate 0.65<x<0.85 0.60<x<0.80 0.50<x<0.65 0.40<x<0.50
Poor x<0.65 x<0.60 x<0.50 x<0.40
Table 2 Categorization of comparators utilized in assessing construct validity
Construct level Definition
Construct 1 Validation against sub-scales or instruments that measure the same impairment
Construct 2 Validation against instruments that measure the same impairment as well as other impairments
Construct 3 Validation against instruments that measure other impairments than the instrument to be validated
Construct 4 Validation against instruments that measure disabilities instead of the domain (impairments) to be validated
Construct 5 Validation against generic instruments that measure impairments as well as disabilities and participation problems
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or more sub-scales. Therefore, whenever possible, the
data were also pooled for the separate sub-scales.
Results
Table 3 presents the impairments in the ICIDH-classi-
fication that are considered to be relevant for people
with rheumatic disorders in allied health care settings.
The number of identified instruments is also shown for
each group of relevant impairments.
In total the search identified 49 measurement instru-
ments for the assessment of impairments in functions in
patients with rheumatic disorders (Table 3). Several of
these 49 instruments measure more than one impair-
ment. Two adapted versions of the AIMS, a multidi-
mensional questionnaire, are included: the AIMS2 and
the AIMSS (for all abbreviations see the Appendix). As
can be observed in Table 3, the categories of impair-
ments that are most frequently assessed by measurement
instruments are pain (n=20; 41%) and impairments in
musculoskeletal and movement related functions (n=15;
33%).
With regard to stiffness, the Visual Analogue Scale-
Stiffness and Morning Stiffness-Duration measure only
stiffness. The BASDAI also measures other aspects of
disease activity, such as (joint) pain, swelling and tired-
ness. Impairments in sensory functions are mainly as-
sessed by instruments that focus on pain, with only one
exception (the AIMS). Fifteen measurement instruments
that were identified only measure impairments in mus-
culoskeletal and movement-related functions. Six of
these instruments have been specifically developed for
assessing patients with ankylosing spondylitis.
Measurement of impairments in mental functions
of patients with rheumatic disorders
Most instruments that measure impairments in mental
functions of patients with rheumatic disorders (they all
concern questionnaires) do not only measure these
impairments, but also other impairments and/or dis-
abilities. Four instruments that were identified focus
only and specifically on impairments in mental functions
(AHI, BDI, SSAI and STAI); the SF-36 and the AIMS
and its modifications have only a sub-scale for measur-
ing mental health, and focus mainly on disabilities.
The AIMS, in different modifications, is the only
questionnaire that meets the criterion for reliability
(Table 4). For the most convergent construct validity
(validated against an optimally-comparable construct),
two questionnaires meet the criterion: BDI (pooled
r=0.67), and STAI (pooled r=0.68). For the imperfect
construct validity, another two questionnaires can be
qualified as ‘‘good’’: the AHI (pooled r=0.69) and the
AIMS-depri (pooled r=0.74). None of the identified
instruments had good reliability as well as good validity.
Measurement of impairments in sensation:
stiffness
There are three available instruments to measure
stiffness: BASDAI, MS-D and VAS-S (Table 4). In all
three, the intra-rater reliability is good. There is a
great variety in the validity of these instruments, with
values that range from 0.26 to 0.70 if validated against
instruments that measure the same impairment (Ta-
ble 4). The highest value is found for the BASDAI
(r=0.70). Only the BASDAI and the VAS-S have
good reliability as well as good validity (shown in
italics in Table 4).
Measurement of impairments in sensory
functions: pain
In total, 20 measurement instruments were identified for
the assessment of pain in patients with rheumatic dis-
orders (two modifications of the AIMS included). Eight
out of these 20 only measure (modalities of) pain: AI,
Dol, MPQ, OPB, P-NRS, RAPS, RPS and VAS-P. All
the others are multidimensional instruments, or repre-
sent a separate sub-scale for pain in a multidimensional
instrument. The results are presented in Table 4.
Reliability studies were performed for all the 20
measurement instruments, with the exception of the EI,
the P-NRS and the RPS. Five of the instruments showed
good reliability: AIMS (pooled r =0.86), AIMS2-pain
(ICC=0.89), ASES (pooled r =0.88), AUSCAN
(ICC=0.89), J-MAP (internal consistency=0.90) and
RAPS (internal consistency=0.92).
Seven instruments showed good convergent construct
validity, with the highest values for the AI, the Dol and
the VAS-P. Seven instruments were found to have
imperfect construct validity, all by correlation with
composite measurement instruments, combining
impairments, disabilities and problems in participation
in one measure. If reliability and construct validity are
both required to be ‘‘good’’, the AIMS and the AU-
SCAN-OHI are the only suitable instruments for pain
assessment.




Impairments in mental functions 11
Impairments in sensation (stiffness) 3
Impairments in sensory functions (pain) 20





In mobility of joints 11
In muscle force 3
Joint swelling 2
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Table 4 Results for reliability and validity concerning measurement instruments per impairment. The best instruments/individual mea-












as well as other
impairments
Disabilities Impairments as well
as disabilities and
participation problems,
or general aspects like,
gender, age
Measurement of impairments in mental functions
AHI [23, 24] 0.53 0.46c 0.69c 0.23 [23]
AIMS [25–46] 0.86c 0.33 [34]
AIMS-anxiety [25–46] 0.43c 0.37 [36]
AIMS-depri [25–46] 0.43c 0.28 [36] 0.74c
AIMS-Emof [25–46] 0.57c 0.19c 0.45c
AIMSS-anxiety [40] 0.41c 0.41c
AIMSS-depri [40] 0.47c 0.14c 0.46c
BDI [24, 47] 0.67c 0.27c 0.64c
SF36 [48–52] 0.66b 0.36c 0.26c 0.35c
SSAI [24] 0.57c 0.47 [24] 0.45c
STAI [24] 0.68c 0.57 [24] 0.51c
Measurement of impairments in sensation (stiffness)
BASDAI [53–55] 0.74 [53–55] 0.70 [53–55] 0.57 [54] 0.67 [54]
MS-D [31, 43, 56, 57] 0.26 [58] 0.16c 0.19c
VAS-S [31, 43, 56–58] 0.93 0.51 [58] 0.91c
Measurement of impairment in sensory functions (pain)
ADLps [60] 0.31 [60]
AI [61–72] 0.84c 0.83b, c 0.83c 0.24c 0.42 [72]
AIMS [25–46] 0.86c 0.58c 0.75c
AIMS-pain [25–46] 0.62 0.40c 0.54c 0.39c 0.60c
AIMS2-pain [32, 46, 73] 0.89b 0.49 [73] 0.38c
AIMSS-pain [41] 0.57 [41] 0.41c 0.50c 0.61c
ASES [74] 0.88c
AUSCAN-OHI [75] 0.84 0.65
Dol [76–85] 0.81c 0.74b, c 0.79c
EI [86] 0.67 [86] 0.36c
FFI [87] 0.84b, c
J-MAP [88] 0.90 0.62 0.41
MPQ [37, 89–92] 0.61c 0.37 [90]
OPB [93, 94] 0.7 [94]
P-NRS [95, 96] 0.32c
RAPS [97] 0.92 0.52, 0.68
RPS [98] 0.53 0.43
SAJ [70] 0.82c 0.55c
Stest [94] 0.67c
VAS-P [31, 43, 57, 76, 95, 96, 99, 100] 0.80c 0.73b, c 0.82c 0.26c 0.73 [100]
Measurement of impairments in joint mobility
BASMI [101] 0.93c
Chest [102] 0.95 [102] 0.53b 0.60 [102]
EDI-abd [103] 0.63b
EPM [104–106] 0.87c 0.87c 0.54 0.54c
Gonio [107] 0.89 [107] 0.92 [107]
MKI [108] 0.90 0.59
MobSpine CCD [109, 110] 0.93b 0.72b 0.37 [110]
MobSpine OWD [96, 109, 110] 0.93b 0.92b 0.49 [110]
Shob [107, 109] 0.95b 0.88b, c 0.66c
Spond [111, 112] 0.92 [111]
Stest [112, 113] 0.97 [113]
Measurement of impairments in muscle force
Gripp [31, 114–116] 0.86c
MSI [117] 0.84 [117] 0.78 [117]
Sphy [118–123] 0.93 [121] 0.87c
Measurement of joint swelling
AI [61–72] 0.80c 0.83b, c 0.82c 0.88c
SAJ [70] 0.77 [63] 0.65 [70]
aFor explanation of abbreviations see Appendix
All values expressed in Pearson’s r of Spearman’s r
bIntra-class correlation coefficient value
cPooled value
Values in italics are instruments that meet the criteria for reliability
as well as for validity. The column ‘‘if validated against instruments
that measure other impairments than the instrument to be vali-
dated’’ is lacking in this Table because those studies were not
appropriate here (because no data are retrieved on this)
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Measurement of impairments in joint mobility
For the assessment of joint mobility in patients with
rheumatic disorders, 11 measurement instruments were
identified (Table 4). On the basis of the available data,
all instruments meet the criterion for intra-rater reli-
ability, with the exception of the EDI. For the BASMI
and the spondylometer there is no available information
concerning reliability. The same was found for the inter-
rater reliability, with the exception of Chest-expansion
(ICC=0.53), and MobSpine-CCD (ICC=0.72). The
BASMI (pooled r =0.93), the goniometer (r =0.92) and
the spondylometer (r =0.92) prove to be valid in pa-
tients with rheumatic disorders if validated against an
optimally comparable construct. If the validity is based
on correlation with an imperfect construct, the EPM and
Shobert’s test can also be qualified as valid. If both
reliability and validity are required to be ‘‘good’’, four
measurement instruments meet the criteria: the Chest-
expansion, the EPM, the goniometer and Shobert’s test.
Measurement of impairments in muscle force
Three instruments were identified to measure impair-
ments in muscle force in patients with rheumatoid
arthritis. The Grippit and the MSI are only intended to
measure hand muscles, but the sphygmomanometer can
also be used for other muscle groups (Table 4).
Only the sphygmomanometer meets the criteria for
both reliability and validity (reliability r =0.93; con-
struct validity r =0.87(pooled)).
Measurement of impairments in swelling
Two instruments are described for the assessment of
(joint) swelling, both of which are sub-scales of an
instrument to assess disease activity (Table 4).
The AI meets the criterion for inter-rater reliability
(pooled r =0.82). The validity of the AI (r =0.88) and
the SAJ (r =0.65) was investigated. The AI was found
to be the best instrument to assess joint swelling in pa-
tients with rheumatic disorders.
Consequences of distinguishing convergent construct
validity (validated against an optimally-comparable
construct) vs divergent construct validity (validated
against an imperfect construct)
Summarizing the data on measurement instruments for
relevant impairments, data on the validity of 40 instru-
ments and/or sub-scales are available. For 21 out of
these 40 measurement instruments, there are data on the
optimally-comparable construct validity as well as the
imperfect construct validity. In 14 of those 21 instru-
ments, the correlation values for the optimally-compa-
rable constructs proved to be higher than the values for
validation against the imperfect constructs. In those
studies reporting that the validity based on the imperfect
constructs was better, in four out of six cases it con-
cerned the AIMS, or modifications or sub-scales of the
AIMS.
Discussion
We identified 49 instruments for the assessment of
impairments in mental functions, stiffness, pain, joint
swelling, mobility and muscle strength in patients with
rheumatic disorders. Sixteen of these instruments were
found to have good reliability, and 24 were found to
have good validity. Only 9 out of the 49 measurement
instruments had good reliability as well as good validity.
None of the identified instruments for the assessment of
impairments in mental functions were both reliable and
valid. With regard to the other impairments, only one to
three instruments per impairment met the criteria for
reliability as well as validity. For assessment of stiffness,
the best instruments are the BASDAI and the VAS-S.
For assessment of pain the best instrument is the AIMS.
For joint mobility, Chest, EPM and Gonio are the best
available instruments, for muscle force the Sphy, and
finally, for assessment of (joint) swelling the best
instrument is the AI. The best available instruments are
given in italics in Table 4.
Clinical consequences of this study
Many measurement instruments are developed for the
assessment of impairments in people with rheumatic
disorders. For clinical use, unidimensionality, good
reliability and good validity are required for a useful
application. The question is not what kind of new
instruments should be developed, but rather which of
the existing measurement instruments should be rejected
because of insufficient quality or lack of information
about their psychometric properties. For at least seven
instruments there is a lack of information concerning
their reliability. This might be a consequence of the fact
that this review was restricted to studies focusing on
populations with rheumatic disorders. The reliability
and validity of the instruments might well have been
investigated in other patient populations. The results of
this review show that six instruments had insufficient
reliability as well as insufficient validity, so there is evi-
dence to justify rejection of those six instruments for
populations with rheumatic disorders: MS-D, ADLps,
MPQ, P-NRS, RPS and EDI-abd.
Many questionnaires that are intended to be used by
people with chronic diseases are multidimensional in
order to get as complete an overview of the impact of the
disease as possible. However, this multidimensionality
makes validation of the questionnaire more complex. It
may be easier to find an optimally-comparable construct
to validate against for unidimensional questionnaires
506
than for a multidimensional questionnaire. For that
reason we analysed data for the separate sub-scales if
possible, in order to study the influence of the validity of
subscales on the validity of the total questionnaire. The
assumption is that each sub-scale is unidimensional,
which is the first requirement of a measurement scale
and also requires a good internal consistency.
It is remarkable that unsatisfactory validity was
found for several sub-scales of the AIMS; namely, the
AIMS-pain, AIMSS-pain, AIMS-anxiety, AIMS-depri
and AIMS-emof. Those (sub-)scales were especially
developed to assess a specific impairment, so one would
expect them to have high correlation values if validated
against an optimally-comparable construct. The reli-
ability of sub-scales of the AIMS has not been investi-
gated. Research on this topic is restricted to the AIMS
as a whole. On the basis of our results it could be con-
cluded that the AIMS as a whole is reliable and valid,
but that there is insufficient evidence for ‘‘good’’ psy-
chometric properties of separate sub-scales of the AIMS.
Furthermore, restrictions to this conclusion must be
made because of the fact that the conclusion regarding
the validity of the AIMS as a whole is based on com-
parison with an imperfect construct. In fact, in general,
construct validity is a way of hypothesis testing, where
the hypothesis is hidden in the hypothetical (theoretical)
constructs. The hypothetical constructs contain pro-
posed underlying factors (which we tried to classify in
Table 2). Possibly the proposed underlying factors
(which are also incorporated in the different items of a
questionnaire) are not fully correct, which might also
explain the differences found in correlations. In fact, the
results of construct validity must be interpreted in a
broader context than only the strength of correlation
with other measures. It is often advocated in the litera-
ture that validity is also related to reliability and internal
consistency, as well as to the proposed underlying fac-
tors in the hypothetical constructs. The results of our
study should be interpreted in the light of this.
Despite the classification of constructs into ‘‘conver-
gent constructs’’ vs ‘‘imperfectly-convergent constructs’’
and our expectation to find stronger correlations in
validation against ‘‘convergent constructs’’, our results
did not confirm this in 100% of cases. In particular,
some impairment-measures showed strong correlations
when validated against disabilities. This could possibly
be explained by the fact that some impairments are good
predictors for certain disabilities. For example ‘‘depres-
sion’’ (AIMS-depri) will have a relative strong impact on
disability and participation problems (correlation r
=0.74; Table 4).
The majority of instruments to measure joint mobil-
ity were found to have good intra- and/or inter-rater
reliability. Some of the instruments are designed for
specific groups of patients: for measuring mobility in
patients with ankylosing spondylitis, the most reliable
and valid available instruments are the Chest-expansion
measurement and Shobert’s test. For patients with
rheumatoid arthritis the best option is the EPM-ROM.
For all rheumatic disorders, in general, the best options
are the goniometer, the spondylometer and the BASMI.
The sphygmomanometer is the most reliable and
valid instrument to assess muscle strength. It is mainly
used for the assessment of grip strength, but can also be
applied to assess the strength of other muscles [119].
When assessing grip strength in particular, the sphyg-
momanometer can measure isometric muscle strength
reliably and quickly.
In this study we did not report the responsiveness of
the identified instruments. So far, research into the
responsiveness of measurement instruments is hampered
by the lack of consensus about the preferred method.
Further research is needed to investigate the respon-
siveness of the identified instruments in the assessment
of impairments.
In this study, several levels of construct validity were
distinguished. We only accepted a value of ‡0.50 as
‘‘good’’ if validated against an imperfect construct, and
a value of ‡0.65 as ‘‘good’’ if validated against an
optimally-comparable construct. Our cut-off points are
based on the literature, but in fact many authors seem to
deviate from literature when interpreting the results of
their own study [106, 124–126]. To our knowledge, dif-
ferent cut-off points for optimally-convergent validity vs
imperfectly-convergent validity have never before been
applied in validation studies. The results of our study
demonstrate that the use of different cut-off points is
justified; most measurement instruments showed better
correlations with optimally-comparable constructs than
with imperfect constructs, and this information is rele-
vant for the interpretation of validity studies in general.
However, the levels of the cut-off points applied in this
study remain arbitrary. Regarding correct interpretation
of the cut-off points for ‘‘good’’ reliability, it must be
emphasized that these also depend on the sample size,
since a sample size of 1,000 can tolerate a much less
reliable instrument than a sample of 10 [21]. The aim of
our study was to give an overview of reliability of
instruments, intended for individual use in clinical situ-
ations. As a consequence of pooling data, the total
number of patients generating our results is large;
therefore, a high cut-off point is required to justify
extrapolation to level of individuals.
The workgroup Outcome Measures in Rheumatoid
Arthritis Clinical Trials
The workgroup Outcome Measures in Rheumatoid
Arthritis Clinical Trials (OMERACT) also emphasizes
the importance of the methodological quality of mea-
surement instruments. OMERACT established a core
set of eight end-points that should be evaluated in clin-
ical trials (disease activity, disability, pain, patient global
assessment, physician global assessment, swollen joint,
tender joint, and joint imaging) [127, 128]. The instru-
ments discussed in this article focus on two of these
domains (pain and the number of tender joints). The
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results of our study might also be useful in selecting the
most appropriate measurement instrument(s) to assess
joint swelling and pain.
In summary, evidence of both reliability and validity
was only found for 11 out of 49 instruments for the
assessment of impairments in patients with rheumatic
disorders. Those 11 best instruments are reflected in bold
in Table 4. In six instruments neither the reliability nor
the validity was found to be adequate. Evidence con-
cerning the reliability and validity of sub-scales of the
AIMS is lacking.
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Appendix
Table a
Table a List of abbreviations of measurement instruments and sub-scales
Abbreviation Name of measurement instrument Abbreviations of sub-scales
AHI Arthritis Helplessness Index Anx, anxiety
Depri, depression
AI Articular Index Pain, pain






























ASES Arthritis Self Efficacy Scale
AUSCAN-OHI Australian/Canadian Osteoarthritis Hand Index Pain, pain
Stiff, stiffness
PhysF, physical function
BASDAI Bath Ankylosing Spondylitis Disease Activity Index
BASMI Bath Ankylosing Spondylitis Metrology Index Stiff-D, stiffness duration
Stiff-S, stiffness severity
BDI Beck Depression Inventory
Chest Chest Expansion
Dol Dolorimeter
EDI Electric Digital Inclinometer-320
EI Enthesis Index
EPM Escola Paulista de Medicina Range of Motion Scale
FFD Finger Floor Distance
FFI Functional Foot Index
Gonio Goniometer
Gripp Grippit
J-MAP Joint-Specific Multidimensional Assessment of Pain
MKI Modified Kapandji Index
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reumatoı̈de artritis. Ned Tijdschr Fysioth 104:86–91
105. Vlieland TP, van Den Ende CH, Breedveld FC, Hazes JM
(1993) Evaluation of joint mobility in rheumatoid arthritis
trials: the value of the EPM-range of motion scale. J Rheu-
matol 20:2010–2014
106. Ferraz MB, Oliveira LM, Araujo PM, Atra E, Walter SD
(1990) EPM-ROM Scale: an evaluative instrument to be used
in rheumatoid arthritis trials. Clin Exp Rheumatol 8:491–494
107. Reynolds PM (1975) Measurement of spinal mobility: a
comparison of three methods. Rheumatol Rehabil 14:180–185
108. Lefevre-Colau MM, Poiraudeau S, Oberlin C (2003) Reli-
ability, validity, and responsiveness of the modified Kapandji
index for assessment of functional mobility of the rheumatoid
hand. Arch Phys Med Rehabil 84:1032–1038
109. Viitanen JV, Kautiainen H, Suni J, Kokko ML, Lehtinen K
(1995) The relative value of spinal and thoracic mobility
measurements in ankylosing spondylitis. Scand J Rheumatol
24:94–97
110. Viitanen JV (1993) Thoracolumbar rotation in ankylosing
spondylitis. A new noninvasive measurement method. Spine
18:880–883
511
111. Sturrock RD, Wojtulewski JA, Hart FD (1973) Spondylom-
etry in a normal population and in ankylosing spondylitis.
Rheumatol Rehabil 12:135–142
112. Roberts WN, Liang MH, Pallozzi LM, Daltroy LH (1988)
Effects of warming up on reliability of anthropometric tech-
niques in ankylosing spondylitis. Arthritis Rheum 31:549–552
113. Newcomer KL, Krug HE, Mahowald ML (1993) Validity and
reliability of the timed-stands test for patients with rheuma-
toid arthritis and other chronic diseases. J Rheumatol 20:21–
27
114. Nordenskiold UM, Grimby G (1993) Grip force in patients
with rheumatoid arthritis and fibromyalgia and in healthy
subjects. A study with the Grippit instrument. Scand
J Rheumatol 22:14–19
115. Dellhag B, Bjelle A (1995) A Grip Ability Test for use in
rheumatology practice. J Rheumatol 22:1559–1565
116. Dellhag B, Hosseini N, Bremell T, Ingvarsson PE (2001)
Disturbed grip function in women with rheumatoid arthritis.
J Rheumatol 28:2624–2633
117. Stucki G, Schonbachler J, Bruhlmann P, Mariacher S, Stoll T,
Michel BA (1994) Does a muscle strength index provide
complementary information to traditional disease activity
variables in patients with rheumatoid arthritis?. J Rheumatol
21:2200–2205
118. Hamilton GF, McDonald C, Chenier TC (1992) Measurement
of grip strength: validity and reliability of the sphygmoma-
nometer and Jamar Grip Dynamometer. J Orthop Sports
Phys Ther 16:215–219
119. Helewa A, Goldsmith CH, Smythe HA (1981) The modified
sphygmomanometer—an instrument to measure muscle
strength: a validation study. J Chronic Dis 34:353–361
120. Helewa A, Goldsmith CH, Smythe HA (1986) Patient, ob-
server and instrument variation in the measurement of
strength of shoulder abductor muscles in patients with rheu-
matoid arthritis using a modified sphygmomanometer.
J Rheumatol 13:1044–1049
121. Spiegel JS, Paulus HE, Ward NB, Spiegel TM, Leake B, Kane
RL (1987) What are we measuring? An examination of walk
time and grip strength. J Rheumatol 14:80–86
122. Lee P, Baxter A, Dick WC, Webb J (1974) An assessment of
grip strength measurement in rheumatoid arthritis. Scand
J Rheumatol 3:17–23
123. Pincus T, Brooks RH, Callahan LF (1991) Reliability of grip
strength, walking time and button test performed according to
a standard protocol. J Rheumatol 18:997–1000
124. Ghiselle EE (1966) The measurement of occupational apti-
tude. Berkely, Los Angeles
125. Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ (1990) Devel-
opment of a self-report questionnaire to assess the impact of
rheumatic diseases on health and lifestyle. J Rehabil Sci 3:65–
70
126. Stewart AL, Ware JE (1992) Measuring functioning and well-
being: the Medical Outcomes Study Approach. Duke Uni-
versity Press, Durham, North Carolina
127. Tugwell P, Boers M (1993) OMERACT conference on out-
come measures in rheumatoid arthritis clinical trials: conclu-
sion. J Rheumatol 20:590
128. Wolfe F, Lassere M, van der HD (1999) Preliminary core set
of domains and reporting requirements for longitudinal
observational studies in rheumatology. J Rheumatol 26:484–
489
512
